Clinical Trials Logo

Filter by:
NCT ID: NCT05776069 Recruiting - Clinical trials for Von Willebrand Diseases

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease

Start date: March 16, 2023
Phase: Phase 1
Study type: Interventional

This is a multi-center, Phase 1a study to assess the safety, tolerability, PK, and PD of VGA039 following single IV or SC dose administration in healthy subjects and Von Willebrand disease patients.

NCT ID: NCT05775848 Recruiting - Clinical trials for Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)

Fortify
Start date: May 31, 2023
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of long-term administration of BBP-418 in patients with LGMD2I/R9. The study will include patients ages 12 to 60, consistent with the existing preclinical toxicology profile. This will encompass the significant majority of existing diagnosed patients based upon the established epidemiology of the disease.

NCT ID: NCT05775159 Recruiting - Clinical trials for Hepatocellular Carcinoma

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

Start date: April 24, 2023
Phase: Phase 2
Study type: Interventional

GEMINI-Hepatobiliary study will assess the efficacy, safety and tolerability of novel immunomodulators alone and in combination with other anticancer drugs in participants with specified advanced solid tumors.

NCT ID: NCT05775055 Active, not recruiting - Clinical trials for Fluid Balance Outcomes

A Comparison of Three Commercial Oral Rehydration Solutions Consumed After Extra-cellular Dehydration

Start date: March 14, 2023
Phase: N/A
Study type: Interventional

Dehydration is commonplace in a number of settings, including exercise, daily living (i.e. inadequate fluid intake) and with relatively common bacterial/viral infections that induce diarrhoea and/or vomiting. As such, it is important to develop effective strategies to facilitate the recovery and maintenance of body water (i.e. rehydration). Whilst rehydration from exercise dehydration has been well-studied, rehydration from other types of dehydration have not. Despite this, oral rehydration solutions have been produced and are commercially available (in chemists/pharmacies and supermarkets) to help recover from dehydration produced by illnesses like diarrhoea and vomiting. Most commercially available oral rehydration solutions use a sugar-base (glucose) and a mixture of electrolytes, but little work has gone into evaluating the efficacy of such solutions. Furthermore, more recent work has explored the use of proteins that they may offer some advantage over sugar/glucose-based beverages. Therefore, the aim of this study is to investigate the efficacy of a protein-based oral rehydration solution compared to two current commercially available glucose-based oral rehydration solutions.

NCT ID: NCT05774951 Recruiting - Clinical trials for Breast Cancer, Early Breast Cancer

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

CAMBRIA-1
Start date: March 31, 2023
Phase: Phase 3
Study type: Interventional

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk for disease recurrence who completed definitive locoregional therapy (with or without chemotherapy) and standard adjuvant endocrine therapy (ET) for at least 2 years and up to 5 years. The planned duration of treatment in either arm of the study is 60 months.

NCT ID: NCT05774756 Enrolling by invitation - Clinical trials for Hypothalamic Obesity

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Start date: April 26, 2023
Phase: Phase 3
Study type: Interventional

The goal of this trial is to learn how well Setmelanotide works to improve weight reduction, hunger, and quality of life in patients 4 years of age and older with acquired Hypothalamic Obesity (HO). To determine how well setmelanotide works and how safe it is, patients with HO will take a daily injection of either setmelanotide or placebo and complete trial assessments for up to 60 weeks.

NCT ID: NCT05774587 Recruiting - Cardiac Event Clinical Trials

Mobile Health for Cardiac Rehabilitation (Motivate-CR+)

Start date: July 6, 2023
Phase: N/A
Study type: Interventional

The investigators aim to conduct a feasibility study to evaluate a model where mobile health (mHealth) technology supports a remote home-based PA and counselling intervention immediately post hospital discharge to increase uptake to cardiac rehabilitation. Our overall objective is to test the feasibility of an evidence-based complex intervention prior to evaluation in a future randomized control trial (RCT)

NCT ID: NCT05774574 Recruiting - Appetitive Behavior Clinical Trials

Physiological and Appetitive Effects of CBD Supplementation

Start date: January 20, 2023
Phase: N/A
Study type: Interventional

CBD may affect metabolic control and energy intake. However, there is currently little data regarding these specific outcomes in humans. Therefore, this study will investigate whether four weeks of supplementation with 60 mg/day CBD affects energy intake at a single meal, and or fasting blood-based markers of appetite regulation and metabolic health. Healthy, adult volunteers will be assigned to placebo or CBD supplementation, in a randomized controlled trial, comparing changes in outcomes across the supplementation period between groups.

NCT ID: NCT05774444 Recruiting - Hypertrophy Clinical Trials

Investigating the Effects of Krill Oil and Krill Protein on Post-exercise Muscle Protein Metabolism

KIPLING
Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The aim of the current study is to find out if krill oil can increase muscle building processes in response to resistance (weightlifting) type exercise. Others aim are to determine the effects of krill protein, and the interaction of krill oil and protein, on muscle building processes in response to resistance (weightlifting) type exercise.

NCT ID: NCT05774184 Recruiting - Clinical trials for Eosinophilic Esophagitis

A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

EvolvE
Start date: June 1, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.